ReShape Lifesciences (RSLSD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period ReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon SystemSeptember 21, 2023 | finanznachrichten.deReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemSeptember 21, 2023 | finance.yahoo.comReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0June 26, 2023 | finance.yahoo.comReShape Lifesciences® to Participate in Investor and Industry Conferences in JuneJune 14, 2023 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call TranscriptMay 17, 2023 | insidermonkey.comReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-MarketApril 20, 2023 | finance.yahoo.comReShape Lifesciences(R) Receives Notice of Allowance for U.S. Patent Related to its Obalon(R) Balloon SystemApril 12, 2023 | marketwatch.comReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to its Obalon® Balloon SystemApril 11, 2023 | finance.yahoo.comReShape Lifesciences postpones earnings releaseMarch 31, 2023 | seekingalpha.comEarnings Outlook For Reshape LifesciencesMarch 28, 2023 | msn.comReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public OfferingFebruary 8, 2023 | benzinga.comWhy Is Reshape Lifesciences (RSLS) Stock Up 136% Today?February 3, 2023 | msn.comReShape Lifesciences Inc. (RSLS) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | seekingalpha.comReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 14, 2022 | yahoo.comReShape Lifesciences to Present at the Q4 Investor SummitNovember 2, 2022 | benzinga.comReShape Lifesciences(TM) Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation(TM) DeviceSeptember 24, 2022 | stockhouse.comReShape Lifesciences™ Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ DeviceSeptember 22, 2022 | nz.finance.yahoo.comReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech ConferenceSeptember 14, 2022 | nz.finance.yahoo.comReshape Lifesciences's Return On Capital Employed OverviewSeptember 9, 2022 | msn.comReShape Lifesciences Appoints Seasoned Sales and Marketing Executive, Nick Ansari, as Senior Vice President of Global Commercial OperationsAugust 23, 2022 | finance.yahoo.comReShape Lifesciences Inc. (RSLS) CEO Paul Hickey on Q2 2022 Results - Earnings Call TranscriptAugust 16, 2022 | seekingalpha.comReShape Lifesciences™ Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateAugust 16, 2022 | finance.yahoo.comReshape Lifesciences Earnings OutlookAugust 12, 2022 | msn.comReShape Lifesciences™ Receives FDA 510(k) Clearance for the GIBI HD™ Calibration Tubes for use in Gastric and Bariatric ProceduresAugust 10, 2022 | nz.finance.yahoo.comReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross ProceedsJune 17, 2022 | finance.yahoo.comReShape Lifesciences receives ~$2.5M in gross proceeds from warrant exerciseJune 17, 2022 | seekingalpha.comReShape Lifesciences™ to Launch Line of ProCare Health® Supplements to Meet Consumers’ Nutritional NeedsNovember 4, 2021 | nz.finance.yahoo.com Remove Ads Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address RSLSD Media Mentions By Week RSLSD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLSD News Sentiment▼0.000.63▲Average Medical News Sentiment RSLSD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLSD Articles This Week▼00▲RSLSD Articles Average Week Remove Ads Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IINN News STRR News SIGY News SINT News MICR News AEMD News LUCY News QNRX News PSTV News AMIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RSLSD) was last updated on 4/8/2025 by MarketBeat.com Staff From Our Partners**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt Discover why Notable Names ...Huge Alerts | SponsoredDividend cuts are destroying retirements… is yours next?The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredTrump’s betrayal exposed Fair warning: this will not make for easy viewing. Especially if you voted for Trump, put your faith in hi...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | SponsoredWill the U.S. military protect this $10B gold mine?You don’t need the gold price to move another inch for this company to potentially re-rate several hundred per...Golden Portfolio | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhy crypto may be the best way to play this chaotic market …Wall Street is in chaos … Over $6 trillion was wiped … in just two days. But something else was happenin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
